Superior Planning LLC’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
Superior Planning LLC's GLUE Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 11 shares worth $131. The stake represents ﹤0.01% of the portfolio and ranks #2066 among its holdings.
125 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Superior Planning LLC held 11 shares of Monte Rosa Therapeutics worth $131 as of Q3 2026.
- Monte Rosa Therapeutics was a new Superior Planning LLC position in Q3 2026.
- Monte Rosa Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #2066 holding.
- 125 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.